Is this your company? Get featured or correct your listing →
Recent changes
- Sep 15, 2026Sep 15, 2026Raised $7.5M SEC EDGAR Form D
Funding History
1 event · sources dated per row| Date | Event | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| Sep 15, 2026 | funding round | $7.5M | — | SEC EDGAR Form D |
Latest Pulse
- Aug 21, 2026Three Biotechs File S-1s in the Same WeekTempest Therapeutics, Aptevo Therapeutics and Alzamend Neuro all filed S-1 registration statements this week, a reminder that the biotech IPO pipeline keeps moving even in a news cycle dominated by trillion-dollar AI listings.→
- Aug 21, 2026Where 2026's Record IPO Money Is Actually LandingBreak 2026's roughly $160B in IPO proceeds down by sector and it's concentrated in a handful of mega-deals -- space, AI and defense -- while smaller biotech, SPAC and fintech listings continue at a steadier pace underneath.→
Coverage Timeline
newest firstAll Coverage
Related Companies
Sources & methodologyshow
Where these figures come from
- SEC EDGAR Form Dprimary source1 fact
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.